| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A look into the future of ALS research
|
Clerc, Pascaline
|
|
2016
|
21 |
6 |
p. 939-949
11 p.
|
artikel
|
| 2 |
Anti-VEGF therapy in ophthalmology: a qualitative analysis of transformative drug development
|
Caplan, Evan S.
|
|
2016
|
21 |
6 |
p. 1019-1026
8 p.
|
artikel
|
| 3 |
BH4 domain of Bcl-2 as a novel target for cancer therapy
|
Liu, Zhiqing
|
|
2016
|
21 |
6 |
p. 989-996
8 p.
|
artikel
|
| 4 |
Bilosomes in the context of oral immunization: development, challenges and opportunities
|
Shukla, Anshuman
|
|
2016
|
21 |
6 |
p. 888-899
12 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2016
|
21 |
6 |
p. ii-
1 p.
|
artikel
|
| 6 |
Contents page 1
|
|
|
2016
|
21 |
6 |
p. i-
1 p.
|
artikel
|
| 7 |
Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?
|
Hird, Nick
|
|
2016
|
21 |
6 |
p. 900-911
12 p.
|
artikel
|
| 8 |
Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors
|
Willemsen, Annelieke E.C.A.B.
|
|
2016
|
21 |
6 |
p. 962-976
15 p.
|
artikel
|
| 9 |
Filtering promiscuous compounds in early drug discovery: is it a good idea?
|
Senger, Mario R.
|
|
2016
|
21 |
6 |
p. 868-872
5 p.
|
artikel
|
| 10 |
From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway
|
Zhan, Mei-Miao
|
|
2016
|
21 |
6 |
p. 1027-1036
10 p.
|
artikel
|
| 11 |
Metal-organic frameworks: mechanisms of antibacterial action and potential applications
|
Wyszogrodzka, Gabriela
|
|
2016
|
21 |
6 |
p. 1009-1018
10 p.
|
artikel
|
| 12 |
Modern approaches to the ocular delivery of cyclosporine A
|
Agarwal, Priyanka
|
|
2016
|
21 |
6 |
p. 977-988
12 p.
|
artikel
|
| 13 |
Molecular basis for cytokine biomarkers of complex 3D microtissue physiology in vitro
|
Asthana, Amish
|
|
2016
|
21 |
6 |
p. 950-961
12 p.
|
artikel
|
| 14 |
Passing on the medicinal chemistry baton: training undergraduates to be industry-ready through research projects between the University of Nottingham and GlaxoSmithKline
|
Macdonald, Simon J.F.
|
|
2016
|
21 |
6 |
p. 880-887
8 p.
|
artikel
|
| 15 |
Recent developments in using mechanistic cardiac modelling for drug safety evaluation
|
Davies, Mark R.
|
|
2016
|
21 |
6 |
p. 924-938
15 p.
|
artikel
|
| 16 |
Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?
|
Arumugam, Somasundaram
|
|
2016
|
21 |
6 |
p. 1003-1008
6 p.
|
artikel
|
| 17 |
Text mining patents for biomedical knowledge
|
Rodriguez-Esteban, Raul
|
|
2016
|
21 |
6 |
p. 997-1002
6 p.
|
artikel
|
| 18 |
The impact of early human data on clinical development: there is time to win
|
Swart, Piet
|
|
2016
|
21 |
6 |
p. 873-879
7 p.
|
artikel
|
| 19 |
The potential of computed crystal energy landscapes to aid solid-form development
|
Price, Sarah L.
|
|
2016
|
21 |
6 |
p. 912-923
12 p.
|
artikel
|
| 20 |
Translatability: what does it mean in drug discovery?
|
Tudor, Matthew
|
|
2016
|
21 |
6 |
p. 865-867
3 p.
|
artikel
|
Tijdschrift beschrijving